- 7ACRES launches new proprietary premium strain, Jack Haze.
- Jack Haze is 7ACRES' first sativa-dominant strain with rare sensory characteristics.
- 7ACRES continues to achieve premium pricing with the launch of Jack Haze.
TORONTO, Sept. 9, 2019 /CNW/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), today announced that its wholly-owned subsidiary, 7ACRES has launched a proprietary strain; Jack Haze.
As 7ACRES' first sativa dominant strain, Jack Haze delivers high THC content with a terpinolene forward profile. Jack haze is one of the few cultivars available with this dominant cannabis terpene, delivering a complex aroma with notes of citrus, pine and warm spice. True to its scent, Jack Haze offers a crisp, zesty, evergreen flavour. In October 2018, 7ACRES went to market with four core stains that were selected for their strong sensory characteristics. As it develops new genetics in-house, 7ACRES continues to prioritize subjective quality.
"Jack Haze's novel name pays homage to the well-known Jack Herer strain, this cultivar's expression possesses a unique Haze profile with a classic, sweet sativa smell and strong visual appeal," said John Fowler, Chief Advocacy Officer and Founder. "As we develop and introduce unique strains, we further differentiate 7ACRES' high end flower offering and continue to achieve premium pricing across Canada."
Jack Haze is the first of 7ACRES' proprietary strains to enter the market. Due to its unique characteristics, Jack Haze achieves 7ACRES' highest average selling price to the provinces. The team responsible for Jack Haze's proprietary genetics selection will be leading Cambium Plant Sciences ("Cambium") genetics business. Cambium will continue to select and develop proprietary genetics for Supreme Cannabis' brands, ensuring the production of differentiated and competitive cannabis products like Jack Haze.
This month, Jack Haze will be available in select provinces that 7ACRES currently supplies.
About Supreme Cannabis.
The Supreme Cannabis Company, Inc., is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the Company has emerged as one of the world's fastest-growing, premium plant driven-lifestyle companies by effectively deploying capital, with an emphasis on disciplined growth and high-quality products.
Supreme Cannabis' portfolio includes 7ACRES, its wholly-owned subsidiary and multi-award-winning brand; Blissco Cannabis Corp., a wellness cannabis brand and a multi-licensed processor and distributor based in British Columbia; Truverra Inc., a global medicinal cannabis brand and licensed cultivator; Cambium Plant Sciences, a plant genetics and cultivation IP company; Medigrow Lesotho, an cannabis oil producer located in southern Africa; Supreme Heights, an investment platform focused on CBD brands in the UK and Europe and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada.
Supreme trades as FIRE on the Toronto Stock Exchange (TSX: FIRE), SPRWF on the OTC Exchange in the United States (OTCQX: SPRWF) and 53S1 on the Frankfurt Stock Exchange (FRA: 53S1). Follow us on Instagram, Twitter, Facebook and YouTube.
We simply grow better.
Certain statements made in this press release may constitute forward-looking information under applicable securities laws. These statements may relate to anticipated events or results and include, but are not limited to, our ability to create shareholder value and other statements that are not historical facts. Particularly, information regarding our expectations of future results, targets, performance achievements, prospects or opportunities is forward-looking information. Often, but not always, forward-looking statements can be identified by the use of forward-looking terminology such as "may", "will", "expect", "believe", "estimate", "plan", "could", "should", "would", "outlook", "forecast", "anticipate", "foresee", "continue" or the negative of these terms or variations of them or similar terminology. Forward-looking statements are current as of the date they are made and are based on applicable estimates and assumptions made by us at the relevant time in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we believe are appropriate and reasonable in the circumstances. However, we do not undertake to update any such forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable securities laws in Canada. There can be no assurance that such estimates and assumptions will prove to be correct. Many factors could cause our actual results, level of activity, performance or achievements or future events or developments to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the factors discussed in the "Risk Factors" section of the Company's Annual Information Form dated October 2, 2018 ("AIF"). A copy of the AIF and the Company's other publicly filed documents can be accessed under the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com. The Company cautions that the list of risk factors and uncertainties described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking information and are cautioned not to place undue reliance on such information.
SOURCE The Supreme Cannabis Company, Inc.
For further information: Nikhil Handa, CFO, Madelin Daviau, Investor Relations, Email: [email protected], Phone: 416-466-6265, supreme.ca